LEIDEN, Netherlands (AP) — LEIDEN, Netherlands (AP) — ProQR Therapeutics NV (PRQR) on Tuesday reported a loss of $6.2 million in its third quarter.
The Leiden, Netherlands-based company said it had a loss of 8 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.
The Dutch drugmaker posted revenue of $1.5 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRQR at https://www.zacks.com/ap/PRQR
Advertisement